Hypolipoproteinemia: Difference between revisions
Line 143: | Line 143: | ||
|- | |- | ||
|Pathogenesis | |Pathogenesis | ||
|Loss of alpha and beta LCAT function | | | ||
Failure of cholesterol ester formation. | *Loss of alpha and beta LCAT function | ||
*Failure of cholesterol ester formation. | |||
|Loss of alpha function only | |Loss of alpha function only | ||
|Pre beta-1 HDL fails to picks up free cholesterol from cells due to mutation in ABCA1 transporter. | | | ||
Pre beta-1 HDL fails to picks up free cholesterol from cells due to mutation in ABCA1 transporter. | |||
|Similar to homozygous | |Similar to homozygous | ||
|- | |- | ||
Line 157: | Line 159: | ||
*Corneal opacities only | *Corneal opacities only | ||
*Normal renal function | *Normal renal function | ||
|Large yellow-orange tonsils | | | ||
*Large yellow-orange tonsils | |||
Dense central corneal opacity | *Dense central corneal opacity | ||
*Relapsing and remitting course of | |||
neuropathy | neuropathy | ||
Line 167: | Line 170: | ||
|- | |- | ||
|Lipid Panel | |Lipid Panel | ||
|Elevated Free cholesterol | | | ||
*Elevated Free cholesterol | |||
HDL-C < 10 mg/dL | *HDL-C < 10 mg/dL | ||
Low Apo A1 and Apo A2 | *Low Apo A1 and Apo A2 | ||
Elevated Apo E and Triglycerides | *Elevated Apo E and Triglycerides | ||
Low LDL C | *Low LDL C | ||
|Elevated free cholesterol | | | ||
*Elevated free cholesterol | |||
HDL C < 27 mg/dL | *HDL C < 27 mg/dL | ||
Apo A1<30mg/dl and low Apo A2 | *Apo A1<30mg/dl and low Apo A2 | ||
Elevated Apo E and Triglycerides | *Elevated Apo E and Triglycerides | ||
Normal LDL and VLDL | *Normal LDL and VLDL | ||
|HDL < 5% of normal | | | ||
*HDL < 5% of normal | |||
Apo A1 < 1% of normal | *Apo A1 < 1% of normal | ||
LDL < 40% of normal | *LDL < 40% of normal | ||
|HDL C, Apo A1 | | | ||
*HDL C, Apo A1 | |||
and LDL 50% less than | and LDL 50% less than | ||
Line 203: | Line 210: | ||
pre-β LDL. | pre-β LDL. | ||
|Only preβ-1 HDL present | |Only preβ-1 HDL present | ||
|Lack of large α-1 and α-2 HDL particles | | | ||
Normal preβ-1 HDL | *Lack of large α-1 and α-2 HDL particles | ||
*Normal preβ-1 HDL | |||
|} | |} | ||
Revision as of 22:12, 19 November 2016
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]; Aravind Kuchkuntla, M.B.B.S[3]; Tarek Nafee, M.D. [4]
Synonyms and keywords: Hypolipidemia, low lipoprotein
Overview
Hypolipoproteinemia is defined as low levels of one or more type of lipoproteins. Hypolipidemia, a commonly used term in the clinical practice, describes low level of lipids, whether cholesterol or triglycerides. They are referred to as hypocholesterolemia and hypotriglyceridemia respectively. Despite being commonly used to describe abnormalities in lipid metabolism, the term hypolipidemia is not very specific. For instance, people who have metabolic syndrome have high LDL and low HDL and yet they are described to have hyperlipidemia when their HDL level is decreased. Moreover, some people who have low levels of a specific lipoprotein may have a normal measured total cholesterol and triglyceride levels.
Synopsis
- It is defined as patients having LDL C less than the 5th percentile when compared to normal population.
- We have to rule out secondary causes first and then consider screening for rare genetic diseases.
Abetalipoprotienemia | Familial Homozygous
Hypobetalipoproteinemia |
Familial Heterozygous
Hypobetalipoproteinemia |
PCSK9 deficiency | Chylomicron Retention
Disease |
Familial Combined
Hypolipidemia | |
---|---|---|---|---|---|---|
LDL C | ↓↓↓ (0) | ↓↓↓ | ↓ | ↓ | ↓↓ | ↓↓ |
Apo B | ↓↓↓( 0) | ↓↓↓ | ↓ | N | ↓↓ | N |
TG | ↓↓↓ | ↓↓↓ | ↓ | ↓ | N | ↓ |
TC | ↓↓↓ | ↓↓↓ | ↓ | ↓ | ↓↓ | ↓ |
HDL | ↓↓ | ↓↓ | N | N | ↓↓ | ↓↓ |
VLDL | ↓↓ | ↓↓ | ↓ | N | ↓↓ | ↓ |
Apo A1 | ↓↓ | ↓↓ | ↓ | N | ↓↓ | N |
Classification
Shown below is an algorithm depicting the classification of hypolipoproteinemia into primary and secondary.
Hypolipoproteinemia | |||||||||||||||||||||||||||||||||||||||||
Primary (Genetic) | Secondary | ||||||||||||||||||||||||||||||||||||||||
Abetalipoproteinemia Apolipoprotein 1 deficiency Chylomicron retention disease Familial combined hypolipidemia Hypobetalipoproteinemia LCAT deficiency Primary alphalipoproteinemia PCSK9 deficiency Tangier disease | Anemia Criticial illness Chronic inflammation Chronic liver disease Hyperthyroidism Infection Malabsorption Malignancy | ||||||||||||||||||||||||||||||||||||||||
Diagnostic Approach to Hypolipoproteinemias
Low LDL Diagnostic Algorithm
The following Algorithm may be used to diagnose patients with low LDL hypolipoproteinemias:
Low LDL C <5th percentile | |||||||||||||||||||||||||||||||
Rule out secondary causes of low LDL | |||||||||||||||||||||||||||||||
Lipid panel | |||||||||||||||||||||||||||||||
Normal Triglycerides | Low Triglycerides | ||||||||||||||||||||||||||||||
Chlyomicron retention disease (Confirm with gene sequencing) | Screen the lipid panel of the patient's parents | ||||||||||||||||||||||||||||||
Normal Parental Lipid Panel | If Parental Lipid Panel <50% of Normal on: *LDL *Total Cholesterol *Triglycerides | ||||||||||||||||||||||||||||||
Hypobetalipoproteinemia (Confirm with gene sequencing) | Abetalipoproteinemia (Confirm with gene sequencing) | ||||||||||||||||||||||||||||||
Low HDL Diagnostic Features
Familial LCAT
Deficiency |
Fish Eye
Disease |
Homozygous Tangier
Disease |
Heterozygous Tangier
Disease | |
---|---|---|---|---|
Gene Defect | LCAT | LCAT | ABCA1 | ABCA1 |
Inheritance | Autosomal Recessive | Autosomal Recessive | Autosomal Recessive | Autosomal Recessive |
Pathogenesis |
|
Loss of alpha function only |
Pre beta-1 HDL fails to picks up free cholesterol from cells due to mutation in ABCA1 transporter. |
Similar to homozygous |
Clinical Features |
|
|
neuropathy |
Asymptomatic |
Lipid Panel |
|
|
|
and LDL 50% less than normal. |
2D Gel Electrophoresis | Pre β-1 and α-4 HDL, LDL with β mobility due to
Lipoprotien-X |
Pre β-1and α-4 HDL with normal
pre-β LDL. |
Only preβ-1 HDL present |
|
References